Find Faculty
M. Margaret Kemeny, MD
img_M. Margaret Kemeny
PROFESSOR | Surgery
email

Schering-Plough Research Institute, Gene Therapy of Primary and Metastatic Malignant\r\nTumors of the Liver Using SCH 58500 (rAd/p53) Via Hepatic Artery Infusion: A\r\nPhase I Study

\r\n

A Two-Stage Phase II Safety and Efficacy\r\n Study of Intradose (Cisplatin/Epinephrine) Injectable Gel Administered to Patients\r\n with Unresectable Intrahepatic Colorectal Metastases

\r\n

A Two-Stage Phase II Safety and Efficacy\r\n Study of IntraDose (Displatin/Epinephrine) Injectable Gel Administered to Patients\r\n with Unresectable Primary Hepatocellular Carcinoma

\r\n

The Long Island Breast Cancer Study Project

\r\n

CALGB protocol 9481: Phase III Study of Hepatic Artery FUDR, Leucovorin (LV)\r\n and Dexamethasone versus systemic 5-Fu and LV as treatment for hepatic metastases\r\n from colorectal cancer

\r\n

ECOG Protocol 3292: Biologic correlates to response and survival in colon\r\n cancer

\r\n

NIH study: Genetics of Breast Cancer Among Women of Jewish Ancestry

\r\n

CALGB protocol 9670: Barriers to Participation of Older Women with Breast\r\n Cancer in Clinical Trials: A Pilot Study

\r\n

Intergroup protocol 9288, SWOG 8990: Combined modality treatment of hepatic\r\n metastases from colorectal cancer

\r\n

Intergroup protocol ECOG 1292, SWOG 9250, CALGB 9395: Phase III Intergroup\r\n prospectively randomiized trial of perioperative 5FU after curative resection\r\n followed by 5 FU/levamisole for patients with colon cancer

\r\n

BS, Harvard College

MD, Columbia University, College of Physicians and Surgeons

Memorial Sloan-Kettering Cancer Center

Memorial Sloan-Kettering Cancer Center

Downstate Medical Center

2000

Surgeon of the Year Award

Surgical Residents, SUNY Stony Brook

1998

Teacher of the Year Award

Surgical Residents, North Shore University Hospital

1972

Award for Scholastic Achievement

American Medical Women's Association, Inc.

124
Publications

Selected Publications

The impact of nativity on uterine cancer survival in the public hospital system of Queens, New York. George S. Hagopian, Alka Chintamani Bapat, Peter R. Dottino, Molly Lieber, M. Margaret Kemeny, Xilian Li, Elianna Kaplowitz, Annmarie Beddoe. Gynecologic Oncology

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292). M. Margaret Kemeny, Fengmin Zhao, Arlene A. Forastiere, Paul Catalano, Stanley R. Hamilton, Brent W. Miedema, Nancy A. Dawson, Louis M. Weiner, Brian D. Smith, Bernard A. Mason, Stephen L. Graziano, Paul B. Gilman, Alan P. Venook, Harlan A. Pinto, Robert P. Whitehead, Peter J. O’Dwyer, Al B. Benson. Annals of Surgical Oncology

Food to Overcome Outcomes Disparities: A Randomized Controlled Trial of Food Insecurity Interventions to Improve Cancer Outcomes. Francesca Gany, Irina Melnic, Minlun Wu, Yuelin Li, Jackie Finik, Julia Ramirez, Victoria Blinder, Margaret Kemeny, Elizabeth Guevara, Caroline Hwang, Jennifer Leng. Journal of Clinical Oncology

View All Publications

Mount Sinai Hospital of Queens

25-10 30th Ave

Long Island City, NY 11102

Queens Hospital (QHC) Room A-531

82-68 164th St

Jamaica, NY 11432

718-883-4031

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Kemeny has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.